Cargando…
Comparison of marker gene expression in chondrocytes from patients receiving autologous chondrocyte transplantation versus osteoarthritis patients
Currently, autologous chondrocyte transplantation (ACT) is used to treat traumatic cartilage damage or osteochondrosis dissecans, but not degenerative arthritis. Since substantial refinements in the isolation, expansion and transplantation of chondrocytes have been made in recent years, the treatmen...
Autores principales: | Stoop, Reinout, Albrecht, Dirk, Gaissmaier, Christoph, Fritz, Jürgen, Felka, Tino, Rudert, Maximilian, Aicher, Wilhelm K |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2007
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2206334/ https://www.ncbi.nlm.nih.gov/pubmed/17596264 http://dx.doi.org/10.1186/ar2218 |
Ejemplares similares
-
Bone morphogenic protein (BMP-2) enhances expression of type II collagen and aggrecan in human chondrocytes in 3D alginate cultures
por: Aicher, WK, et al.
Publicado: (2004) -
Therapeutic strategy of third-generation autologous chondrocyte implantation for osteoarthritis
por: Kuroda, Tomoya, et al.
Publicado: (2011) -
Comparison of Hydrogel-Based Autologous Chondrocyte Implantation Versus Microfracture: A Propensity Score Matched-Pair Analysis
por: Niemeyer, Philipp, et al.
Publicado: (2023) -
AUTOLOGOUS CHONDROCYTE IMPLANTATION IN BRAZIL
por: GIGLIO, PEDRO NOGUEIRA, et al.
Publicado: (2020) -
A Meta-Analysis of Non-Osteoarthritis and Osteoarthritis Chondrocyte Gene Expression to Determine the Efficacy of Autologous Chondrocyte Transplantation as a Viable Treatment Option
por: Tran, Tien M., et al.
Publicado: (2019)